SHARE
 
Andrew M. Baschnagel, MD close
Andrew M. Baschnagel, MD

New Patients

Contact the Welcome Center for help choosing a new primary care doctor.

For Referring Physicians

How to refer a patient

Andrew M. Baschnagel, MD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Baschnagel is a radiation oncologist and assistant professor in the Department of Human Oncology at the University of Wisconsin School of Medicine and Public Health, Madison, WI. He specializes in treating patients with lung, esophageal and other thoracic malignancies. He also has experience in performing stereotactic body radiotherapy and intracranial stereotactic radiosurgery for the treatment of brain, spine and liver metastases. He is actively involved in UW Multidisciplinary Thoracic Program and works closely with thoracic surgeons, medical oncologists, pulmonologists and radiologists to best meet the needs of our patients. In addition to patient care, he is actively involved in translational and clinical research at the regional and national level. 

Specialties

Clinics

UW Carbone Cancer Center
(608) 265-1700 | (800) 323-8942 | Map
UW Carbone Cancer Center
(608) 263-8500 | (800) 323-8942 | Map

UW School of Medicine and Public Health

Department of Human Oncology

Professional Certifications and Education

Board Certification Radiation Oncology
Residency William Beaumont Hospital, Royal Oak, MI
Internship William Beaumont Hospital, Royal Oak, MI
Medical School The State University of New York at Buffalo, Buffalo, NY

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.
Research

Dr. Baschnagel’s research focuses on translational and clinical research.  He works closely with basic scientists, physicists and clinicians with the goal of fostering new ideas and translating research findings into the clinic. He has experience in studying combinations of radiation and molecular targeted agents and biomarkers of treatment response in patients and in preclinical models. His current work focuses on improving treatment of non-small cell lung cancer, esophageal cancer  and head and neck cancer. 



PubMed Articles
Fisher MM SenthilKumar G Hu R Goldstein S Ong IM Miller MC Brennan SR Kaushik S Abel L Nickel KP Iyer G Harari PM Kimple RJ Baschnagel AM Fibroblast Growth Factor Receptors as Targets for Radiosensitization in Head and Neck Squamous Cell Carcinomas. Int J Radiat Oncol Biol Phys . 2020 Jul 15;107(4):793-803
[PubMed ID: 32298810]
Wallat EM Flakus MJ Wuschner AE Shao W Christensen GE Reinhardt JM Baschnagel AM Bayouth JE Modeling the impact of out-of-phase ventilation on normal lung tissue response to radiation dose. Med Phys . 2020 Jul;47(7):3233-3242
[PubMed ID: 32187683]
Siddiqui ZA Squires BS Johnson MD Baschnagel AM Chen PY Krauss DJ Olson RE Meyer KD Grills IS Predictors of radiation necrosis in long-term survivors after Gamma Knife stereotactic radiosurgery for brain metastases. Neurooncol Pract . 2020 Jul;7(4):400-408
[PubMed ID: 32765891]
SenthilKumar G Fisher MM Skiba JH Miller MC Brennan SR Kaushik S Bradley ST Longhurst CA Buehler D Nickel KP Iyer G Kimple RJ Baschnagel AM FGFR Inhibition Enhances Sensitivity to Radiation in Non-Small Cell Lung Cancer. Mol Cancer Ther . 2020 Jun;19(6):1255-1265
[PubMed ID: 32371583]
Käsmann L Janssen S Baschnagel AM Kruser TJ Harada H Aktan M Rades D Prognostic factors and outcome of reirradiation for locally recurrent small cell lung cancer-a multicenter study. Transl Lung Cancer Res . 2020 Apr;9(2):232-238
[PubMed ID: 32420062]
Wilson TG Hanna A Recknagel J Pruetz BL Baschnagel AM Wilson GD Prognostic significance of MTOR expression in HPV positive and negative head and neck cancers treated by chemoradiation. Head Neck . 2020 Feb;42(2):153-162
[PubMed ID: 31657099]
Musunuru HB Witt JS Yadav P Francis DM Kuczmarska-Haas A Labby ZE Bassetti MF Howard SP Baschnagel AM Impact of adjuvant fractionated stereotactic radiotherapy dose on local control of brain metastases. J Neurooncol . 2019 Nov;145(2):385-390
[PubMed ID: 31606876]
Sebastian N Wu T Driscoll E Willers H Kelly S Musunuru HB Mo X Tan Y Bazan J Haglund K Xu-Welliver M Baschnagel AM Ju A Keane F Williams TM Pre-treatment serum bicarbonate predicts for primary tumor control after stereotactic body radiation therapy in patients with localized non-small cell lung cancer. Radiother Oncol . 2019 Nov;140:26-33
[PubMed ID: 31176206]
Yadav P Musunuru HB Witt JS Bassetti M Bayouth J Baschnagel AM Dosimetric study for spine stereotactic body radiation therapy: magnetic resonance guided linear accelerator versus volumetric modulated arc therapy. Radiol Oncol . 2019 Sep 24;53(3):362-368
[PubMed ID: 31553704]
Witt JS Jagodinsky JC Liu Y Yadav P Kuczmarska-Haas A Yu M Maloney JD Ritter MA Bassetti MF Baschnagel AM Cardiac Toxicity in Operable Esophageal Cancer Patients Treated With or Without Chemoradiation. Am J Clin Oncol . 2019 Aug;42(8):662-667
[PubMed ID: 31313677]
Liu F Yadav P Baschnagel AM McMillan AB MR-based treatment planning in radiation therapy using a deep learning approach. J Appl Clin Med Phys . 2019 Mar;20(3):105-114
[PubMed ID: 30861275]
Yu JB Beck TF Anscher MS Baschnagel AM Brock KK Carlson DJ Dominello MM Kimple RJ Knisely JPS Mendonca MS Mian OY Singh AK Moros EG Keen JC The ASTRO Research Portfolio: Where Do We Go From Here? Int J Radiat Oncol Biol Phys . 2019 Feb 1;103(2):308-309
[PubMed ID: 30647008]
Yu JB Beck TF Anscher MS Baschnagel AM Brock KK Carlson DJ Dominello MM Kimple RJ Knisely JP Mendonca MS Mian OY Singh AK Moros EG Keen JC Analysis of the 2017 American Society for Radiation Oncology (ASTRO) Research Portfolio. Int J Radiat Oncol Biol Phys . 2019 Feb 1;103(2):297-304
[PubMed ID: 30647006]
Davidson SM Ko HC Harari PM Wieland AM Chen S Baschnagel AM Kimple RJ Witek ME Impact of HPV Status on the Prognostic Potential of the AJCC Staging System for Larynx Cancer. Otolaryngol Head Neck Surg . 2018 Sep;159(3):456-465
[PubMed ID: 29611770]
Hall WA Bergom C Thompson RF Baschnagel AM Vijayakumar S Willers H Li XA Schultz CJ Wilson GD West CML Capala J Coleman CN Torres-Roca JF Weidhaas J Feng FY Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference. Int J Radiat Oncol Biol Phys . 2018 Jun 1;101(2):274-284
[PubMed ID: 28964588]
Mittauer K Paliwal B Hill P Bayouth JE Geurts MW Baschnagel AM Bradley KA Harari PM Rosenberg S Brower JV Wojcieszynski AP Hullett C Bayliss RA Labby ZE Bassetti MF A New Era of Image Guidance with Magnetic Resonance-guided Radiation Therapy for Abdominal and Thoracic Malignancies. Cureus . 2018 Apr 4;10(4):e2422
[PubMed ID: 29872602]
Burr AR Harari PM Ko HC Chen S Yu M Baschnagel AM Kimple RJ Witek ME HPV impacts survival of stage IVC non-oropharyngeal HNSCC cancer patients. Otorhinolaryngol Head Neck Surg . 2018;3(1)
[PubMed ID: 30271885]
Ko HC Chen S Wieland AM Yu M Baschnagel AM Hartig GK Harari PM Witek ME Clinical outcomes for patients presenting with N3 head and neck squamous cell carcinoma: Analysis of the National Cancer Database. Head Neck . 2017 Nov;39(11):2159-2170
[PubMed ID: 28737019]
Ko HC Harari PM Sacotte RM Chen S Wieland AM Yu M Baschnagel AM Bruce JY Kimple RJ Witek ME Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas. J Cancer Res Clin Oncol . 2017 Nov;143(11):2341-2350
[PubMed ID: 28752235]
Ko HC Harari PM Chen S Wieland AM Yu M Baschnagel AM Kimple RJ Witek ME Survival Outcomes for Patients With T3N0M0 Squamous Cell Carcinoma of the Glottic Larynx. JAMA Otolaryngol Head Neck Surg . 2017 Nov 1;143(11):1126-1133
[PubMed ID: 29049434]